Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1110424

Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?


Papakonstantinou, Panteleimon E.; Borovac, Josip Anđelo; Gasecka, Aleksandra; Bongiovanni, Dario; Ehrlinder, Hanne; Giustozzi, Michela; Parker, William A.E.; Azevedo Guerreiro, Rui
Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy? // European Journal of Preventive Cardiology, 28 (2021), zwab021, 3 doi:10.1093/eurjpc/zwab021 (međunarodna recenzija, komentar, znanstveni)


CROSBI ID: 1110424 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?
(Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?)

Autori
Papakonstantinou, Panteleimon E. ; Borovac, Josip Anđelo ; Gasecka, Aleksandra ; Bongiovanni, Dario ; Ehrlinder, Hanne ; Giustozzi, Michela ; Parker, William A.E. ; Azevedo Guerreiro, Rui

Izvornik
European Journal of Preventive Cardiology (2047-4873) 28 (2021); Zwab021, 3

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, komentar, znanstveni

Ključne riječi
atrial fibrillation ; anticoagulation ; NOAC ; DOAC ; novel oral anticoagulants ; interactions ; warfarin

Sažetak
This article deals about initiation of NOAC therapy in COVID- 19 outpatients with non-valvular atrial fibrillation vs. vitamin K antagonists.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url JOSIP ANĐELO BOROVAC (autor)

Citiraj ovu publikaciju

Papakonstantinou, Panteleimon E.; Borovac, Josip Anđelo; Gasecka, Aleksandra; Bongiovanni, Dario; Ehrlinder, Hanne; Giustozzi, Michela; Parker, William A.E.; Azevedo Guerreiro, Rui
Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy? // European Journal of Preventive Cardiology, 28 (2021), zwab021, 3 doi:10.1093/eurjpc/zwab021 (međunarodna recenzija, komentar, znanstveni)
Papakonstantinou, P., Borovac, J., Gasecka, A., Bongiovanni, D., Ehrlinder, H., Giustozzi, M., Parker, W. & Azevedo Guerreiro, R. (2021) Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?. European Journal of Preventive Cardiology, 28, zwab021, 3 doi:10.1093/eurjpc/zwab021.
@article{article, year = {2021}, pages = {3}, DOI = {10.1093/eurjpc/zwab021}, chapter = {zwab021}, keywords = {atrial fibrillation, anticoagulation, NOAC, DOAC, novel oral anticoagulants, interactions, warfarin}, journal = {European Journal of Preventive Cardiology}, doi = {10.1093/eurjpc/zwab021}, volume = {28}, issn = {2047-4873}, title = {Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?}, keyword = {atrial fibrillation, anticoagulation, NOAC, DOAC, novel oral anticoagulants, interactions, warfarin}, chapternumber = {zwab021} }
@article{article, year = {2021}, pages = {3}, DOI = {10.1093/eurjpc/zwab021}, chapter = {zwab021}, keywords = {atrial fibrillation, anticoagulation, NOAC, DOAC, novel oral anticoagulants, interactions, warfarin}, journal = {European Journal of Preventive Cardiology}, doi = {10.1093/eurjpc/zwab021}, volume = {28}, issn = {2047-4873}, title = {Anticoagulation therapy in non-valvular atrial fibrillation in the COVID-19 era: is it time to reconsider our therapeutic strategy?}, keyword = {atrial fibrillation, anticoagulation, NOAC, DOAC, novel oral anticoagulants, interactions, warfarin}, chapternumber = {zwab021} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font